These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 15644992
1. The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. Shen J, Kennedy SH, Levitan RD, Kayumov L, Shapiro CM. J Psychiatry Neurosci; 2005 Jan; 30(1):11-6. PubMed ID: 15644992 [Abstract] [Full Text] [Related]
2. Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study. Saiz-Ruiz J, Ibañez A, Díaz-Marsá M, Arias F, Carrasco JL, Huertas D, Martín-Carrasco M, Moreno I, Rico-Villademoros F. CNS Drugs; 2002 Jan; 16(9):635-43. PubMed ID: 12153334 [Abstract] [Full Text] [Related]
3. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial. Gillin JC, Rapaport M, Erman MK, Winokur A, Albala BJ. J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611 [Abstract] [Full Text] [Related]
4. An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder. Gillin JC, Smith-Vaniz A, Schnierow B, Rapaport MH, Kelsoe J, Raimo E, Marler MR, Goyette LM, Stein MB, Zisook S. J Clin Psychiatry; 2001 Oct; 62(10):789-96. PubMed ID: 11816868 [Abstract] [Full Text] [Related]
5. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression. Feighner J, Targum SD, Bennett ME, Roberts DL, Kensler TT, D'Amico MF, Hardy SA. J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036 [Abstract] [Full Text] [Related]
6. The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression. Manber R, Rush AJ, Thase ME, Amow B, Klein D, Trivedi MH, Korenstein SG, Markowitz JC, Dunner DL, Munsaka M, Borian FE, Martin, Keller B. Sleep; 2003 Mar 15; 26(2):130-6. PubMed ID: 12683470 [Abstract] [Full Text] [Related]
7. The effect of nefazodone on subjective and objective sleep quality in posttraumatic stress disorder. Neylan TC, Lenoci M, Maglione ML, Rosenlicht NZ, Leykin Y, Metzler TJ, Schoenfeld FB, Marmar CR. J Clin Psychiatry; 2003 Apr 15; 64(4):445-50. PubMed ID: 12716248 [Abstract] [Full Text] [Related]
8. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone. Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP. J Clin Psychiatry; 1999 Apr 15; 60(4):226-31. PubMed ID: 10221282 [Abstract] [Full Text] [Related]
9. An open-label study of nefazodone treatment of major depression in patients with congestive heart failure. Lespérance F, Frasure-Smith N, Laliberté MA, White M, Lafontaine S, Calderone A, Talajic M, Rouleau JL. Can J Psychiatry; 2003 Nov 15; 48(10):695-701. PubMed ID: 14674053 [Abstract] [Full Text] [Related]
10. Fluoxetine treatment of depressed patients with comorbid anxiety disorders. Sonawalla SB, Farabaugh A, Johnson MW, Morray M, Delgado ML, Pingol MG, Rosenbaum JF, Fava M. J Psychopharmacol; 2002 Sep 15; 16(3):215-9. PubMed ID: 12236627 [Abstract] [Full Text] [Related]
11. An open-label trial of nefazodone in high comorbidity panic disorder. DeMartinis NA, Schweizer E, Rickels K. J Clin Psychiatry; 1996 Jun 15; 57(6):245-8. PubMed ID: 8666561 [Abstract] [Full Text] [Related]
12. Response of anxiety and agitation symptoms during nefazodone treatment of major depression. Fawcett J, Marcus RN, Anton SF, O'Brien K, Schwiderski U. J Clin Psychiatry; 1995 Jun 15; 56 Suppl 6():37-42. PubMed ID: 7649972 [Abstract] [Full Text] [Related]
13. The effects of nefazodone on sleep architecture in depression. Armitage R, Rush AJ, Trivedi M, Cain J, Roffwarg HP. Neuropsychopharmacology; 1994 Apr 15; 10(2):123-7. PubMed ID: 8024673 [Abstract] [Full Text] [Related]
14. Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. Ninan PT, Rush AJ, Crits-Christoph P, Kornstein SG, Manber R, Thase ME, Trivedi MH, Rothbaum BO, Zajecka J, Borian FE, Keller MB. J Clin Psychiatry; 2002 May 15; 63(5):434-41. PubMed ID: 12025827 [Abstract] [Full Text] [Related]
15. Symptom clusters as predictors of late response to antidepressant treatment. Trivedi MH, Morris DW, Grannemann BD, Mahadi S. J Clin Psychiatry; 2005 Aug 15; 66(8):1064-70. PubMed ID: 16086624 [Abstract] [Full Text] [Related]
16. A preliminary open trial of nefazodone added to mood stabilizers for bipolar depression. Goldberg JF. J Affect Disord; 2013 Jan 10; 144(1-2):176-8. PubMed ID: 22858262 [Abstract] [Full Text] [Related]
17. Modafinil treatment in patients with seasonal affective disorder/winter depression: an open-label pilot study. Lundt L. J Affect Disord; 2004 Aug 10; 81(2):173-8. PubMed ID: 15306145 [Abstract] [Full Text] [Related]
18. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies. Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D. Clin Ther; 2009 Jun 10; 31 Pt 1():1405-23. PubMed ID: 19698901 [Abstract] [Full Text] [Related]
19. Nefazodone in primary insomnia: an open pilot study. Wiegand MH, Galanakis P, Schreiner R. Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov 10; 28(7):1071-8. PubMed ID: 15610919 [Abstract] [Full Text] [Related]
20. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Rush AJ, Armitage R, Gillin JC, Yonkers KA, Winokur A, Moldofsky H, Vogel GW, Kaplita SB, Fleming JB, Montplaisir J, Erman MK, Albala BJ, McQuade RD. Biol Psychiatry; 1998 Jul 01; 44(1):3-14. PubMed ID: 9646878 [Abstract] [Full Text] [Related] Page: [Next] [New Search]